secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K/A
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001558370-24-008542
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus discloses terms of senior secured term loan and revenue participation sale
--------------------------------------------------------------------------------

- Filed Loan Agreement: senior secured term loan from multiple lenders, interest at Term SOFR + margin, maturity date TBD.
- Loan includes makewhole amount for prepayment within first year and prepayment premium.
- Filed Revenue Purchase and Sale Agreement with Coduet Royalty Holdings LLC; terms not disclosed.
- Guarantors include Coherus Intermediate, Intekrin Therapeutics, Surface Oncology, Coherus Oncology Supportive Care.
- Minimum liquidity covenant required; specific amount not disclosed in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024008542/0001558370-24-008542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024008542/chrs-20240508x8ka.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer